Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy of cyclosporine at 2, 5 mg/kg/day bid (i.e. bis in a
day), when administered twice a week compared to continuous administration, in patients with
chronic plaque psoriasis.